Nobuyuki Koga

6PUBLICATIONS
6CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular medicineGene and molecular therapyTraditional Chinese medicine and treatmentsEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 24, 2023
Fremanezumab for Episodic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials.

Kazumasa Saigoh, Takao Takeshima, Masami Nakai

|Apr 27, 2023
Fremanezumab for Chronic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials.

Kazumasa Saigoh, Takao Takeshima, Masami Nakai

|Dec 29, 2022
A multicenter, open-label, phase 3 study to evaluate the safety of fremanezumab for migraine, subcutaneously self-administered with an auto-injection device at institutional sites and at home.

Koichi Hirata, Takao Takeshima, Noboru Imai

|Oct 23, 2021
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study.

Fumihiko Sakai, Norihiro Suzuki, Xiaoping Ning

|Jul 29, 2021
Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.

Fumihiko Sakai, Norihiro Suzuki, Byung-Kun Kim

|Jul 29, 2021
Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.

Fumihiko Sakai, Norihiro Suzuki, Byung-Kun Kim

Pageof 1

Frequent Collaborators

3 joint publications

Fumihiko Sakai

3 joint publications

Norihiro Suzuki

3 joint publications

Masami Nakai

2 joint publications

Byung-Kun Kim